NBC Securities Inc. Sells 611 Shares of First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH)

NBC Securities Inc. lessened its stake in First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) by 9.9% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,536 shares of the company’s stock after selling 611 shares during the period. NBC Securities Inc. owned 0.92% of First Trust Nasdaq Pharmaceuticals ETF worth $159,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the company. International Assets Investment Management LLC bought a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF during the second quarter worth $73,000. Ameritas Investment Partners Inc. increased its position in First Trust Nasdaq Pharmaceuticals ETF by 5.5% in the first quarter. Ameritas Investment Partners Inc. now owns 11,200 shares of the company’s stock worth $314,000 after purchasing an additional 587 shares during the period. Finally, Janney Montgomery Scott LLC bought a new stake in First Trust Nasdaq Pharmaceuticals ETF during the 1st quarter worth about $1,030,000.

First Trust Nasdaq Pharmaceuticals ETF Trading Up 0.1 %

Shares of NASDAQ FTXH opened at $28.81 on Friday. The firm has a market capitalization of $17.29 million, a PE ratio of 15.98 and a beta of 0.70. The firm’s 50-day moving average is $28.94 and its 200-day moving average is $27.79. First Trust Nasdaq Pharmaceuticals ETF has a 1 year low of $23.85 and a 1 year high of $29.72.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, September 30th. Shareholders of record on Thursday, September 26th were given a dividend of $0.1218 per share. This represents a $0.49 annualized dividend and a dividend yield of 1.69%. The ex-dividend date of this dividend was Thursday, September 26th.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.